コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 CNV was present in 148 patients (49%) and retinal atroph
2 CNVs comprise a large proportion of variation in human g
3 CNVs have large mirror effects on FC at the global and r
4 CNVs hitting loss-of-function intolerant genes were asso
5 CNVs were generated from exome sequencing of 4913 schizo
6 presence of treatment-naive quiescent type 1 CNV and by a factor of 0.46 (95% CI, 0.41-0.51) in the p
10 ing magnetic resonance imaging data from 101 CNV carriers, 755 individuals with idiopathic ASD, SZ, o
12 uding the well-established pathway of type 2 CNV progression to FGL and the progression of type 1 fib
13 verse phenotypes in individuals with 16p11.2 CNVs, and synthesize preclinical findings from transgeni
19 A events from TCGA and COSMIC; (iii) 112 674 CNV-ceRNA events from TCGA; (iv) 67 066 SNP-ceRNA events
21 pact of gene dosage variation triggered by a CNV spanning the SEC10 gene on SEC10 expression at both
24 their flexibility in modeling the aggregate CNV effects, their ability to capture effects from diffe
26 set of voltage-gated calcium channels among CNVs called from both exome sequencing and genotyping ar
29 ns between the extent of angioid streaks and CNV or macular atrophy were investigated using regressio
31 55 different pathogenic point mutations and CNVs in 13 genes/loci responsible for nonsyndromic and s
32 findings, facial morphological variants, and CNVs, statistically significant relationships were found
36 ce that carriers of schizophrenia-associated CNVs had poorer block design performance (P = 0.0307).
37 arriers of specific schizophrenia-associated CNVs showed poorer performance than non-carriers in imme
38 prevalence and penetrance of large autosomal CNVs and chromosomal aneuploidies using a standard CNV d
40 zumab every 4 weeks with documented baseline CNV type, total area, and leakage area were analyzed.
42 additional evidence for the role of baseline CNV features (CNV type, total area, and leakage area) in
48 and transposable elements (TEs) affected by CNVs, we revealed that the variation statuses of genes a
54 Similar results were observed when comparing CNV Radar calls to single nucleotide polymorphism array
55 ed for development of macular complications (CNV, large areas of RPE atrophy [at least 250 mum in dia
56 e rate with FISH for del17p, a risk defining CNV event (88% in POLLUX and 90% in CASTOR), therefore a
57 uggest that CONCUR is well powered to detect CNV effects in the Swedish Schizophrenia Study and the T
58 n OCT alone can be relied upon for detecting CNV activity while monitoring eyes with neovascular AMD.
59 ivity and specificity of SD OCT in detecting CNV activity was 91% (95% confidence interval [CI], 84%-
62 ir ability to capture effects from different CNV features, and their accommodation of effect heteroge
66 ree from a definition of locus and evaluates CNV-phenotype associations by comparing individuals' cop
68 =7), RPE atrophy with a history of exudative CNV (n=10), and RPE atrophy without evidence of coexisti
69 xima A), 3.55 (0.16) mm(2) in the fellow eye CNV cohort (Proxima B), and 2.96 (0.25) mm(2) in the fel
70 29) and -7.57 (1.26) in Proxima B fellow eye CNV cohort, and -11.48 (3.39) and -8.37 (3.02) in Proxim
72 dence for the role of baseline CNV features (CNV type, total area, and leakage area) in influencing v
75 expected role of non-NLRP3 inflammasomes for CNV and suggest that combination therapies targeting inf
76 ate that the utility of exome sequencing for CNV calling has yet to be maximized, and note that singl
81 ExomeDepth) to expand our set of single-gene CNVs and leveraged two different approaches for validati
82 t to be maximized, and note that single-gene CNVs should be included in gene-focused studies using ot
83 to the potential contribution of single-gene CNVs to schizophrenia, indicate that the utility of exom
86 st patient, sequenced using the 10X Genomics CNV solution with sequencing coverage ~0.03x, SBMClone r
90 neralized epilepsy patients have the highest CNV burden in all categories tested, followed by develop
93 We found no evidence of association of HP CNV or rs200999 with functional outcome, ICH volume or P
99 tients into three groups according to the HP CNV: 1-1, 2-1 or 2-2 and also dichotomised HP into HP1-c
100 ing-based transcriptional signature of human CNV, characterizes its compositional pattern of immune a
101 e rare variant association studies, identify CNVs associated with major disease categories, and illus
103 the en-face and the cross-sectional images, CNV was identified in 13 eyes with the rest OCT-A and in
105 CNV, (2) whether inflammasome activation in CNV occurs via NLRP3 or also through NLRP3-independent m
107 brain-behavior relationships were altered in CNV carriers, we further tested for interactions between
108 However, we observed striking differences in CNV burden across epilepsy types and investigated CNV ca
109 cal epilepsy patients, showed an increase in CNV burden in at least one tested category compared to c
111 ration of a stringent filtering procedure in CNV studies with suitable bioinformatics approaches can
113 n processing speed and cortical thickness in CNV carriers, implicate aberrant development of the cort
114 des functionality for summarizing individual CNV calls across a population, assessing overlap with fu
116 163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes
120 Herein, we report a case of inflammatory CNV during pregnancy and describe a previously unreporte
126 k and which epilepsy subtypes carry the most CNV burden, have not been explored on a genome-wide scal
127 tive and safe drug in cases of active myopic CNV; however, a larger number of patients and a longer f
129 h the absence of tomographic signs of myopic CNV, and the presence on autofluorescence of multiple hy
132 itical role in choroidal neovascularization (CNV) and may, therefore, be potential targets to modulat
133 he type of the choroidal neovascularization (CNV) at the start of treatment were similar between the
135 d in promoting choroidal neovascularization (CNV) in age-related macular degeneration (AMD), but cent
136 nal profile of choroidal neovascularization (CNV) in body donor eyes with neovascular age-related mac
140 mmune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-re
142 eral cognitive ability than nonschizophrenia CNV carriers in discovery (beta = -0.66, 95% confidence
143 CoDE-seq also identified 28 rare or novel CNVs associated with intellectual disability in 22 addit
146 of 15 letters or more than eyes with occult CNV (mean BCVA, 57.9 letters at baseline; P < 0.01).
149 ntation artifacts and incomplete coverage of CNV on SS-OCTA en face images may impede identification
150 th early/intermediate AMD and a diagnosis of CNV in the fellow eye progressed to CNV fastest (at a ra
152 The proposed method captures the effects of CNV dosage and length, accounts for the numerical nature
154 uid, and/or cystoid spaces); (2) evidence of CNV activity on FFA identified by the presence of leakag
155 D OCT data were analyzed for (1) evidence of CNV activity on SD OCT (presence of subretinal fluid, in
159 clinical implications for the management of CNV and lead to new therapeutic strategies to prevent at
162 streaks was associated with the presence of CNV when adjusted for age and sex (odds ratio, 1.9; 95%
163 aks are associated with an increased risk of CNV and macular atrophy, even after adjustment for age.
165 ence of leakage, and (3) cross-tabulation of CNV activity identified by FFA and SD OCT by office visi
171 use it to annotate regulatory disruption of CNVs from 14,891 independent genome-sequenced individual
176 ical analyses revealed that the incidence of CNVs increases significantly in SD-rich regions, indicat
177 omic resource for unveiling the incidence of CNVs that affect gene content and for identifying sequen
178 tal detection and computational inference of CNVs from SNP array and next-generation sequencing data
180 significantly associated with the number of CNVs (OR 1.20, 95% CI 1.00-1.44, p = 0.05, adjusted OR f
181 etic cause, with 13% of these as a result of CNVs, demonstrating a remarkably higher prevalence of mo
184 elivers a comprehensive genome-wide study of CNVs affecting barley gene content and implicates SDs in
186 at CNV Radar was able to detect a variety of CNVs associated with risk of progression, and we observe
187 EGs, as confirmed by immunohistochemistry on CNV tissue and protein analysis of vitreous samples.
188 The model applied in this study, trained on CNVs encompassing >4,500 genes, suggests highly polygeni
191 ermediate AMD, rates of progression to GA or CNV were 2.0 and 3.2 per 100 person-years, respectively.
192 led 3 progression pathways from the original CNV: 1) progression to type A, followed by RPE erosion a
193 that CNV Radar is more sensitive than other CNV detection methods, accurately detects clinically imp
199 um (RPE) or rather in non-RPE cells promotes CNV, (2) whether inflammasome activation in CNV occurs v
203 (RPE) atrophy with treatment-naive quiescent CNV (n=7), RPE atrophy with a history of exudative CNV (
206 model to predict expression effects of rare CNVs and use it to annotate regulatory disruption of CNV
207 al profiles associated with these reciprocal CNVs in conjunction with brain imaging measures have not
209 d 2,241 eligible genes in the 1,532 reported CNVs, of which they classified 432 as high-priority ADHD
210 q13.3 deletion represents the strongest risk CNV for genetic generalized epilepsy across the whole ge
211 Our findings show that the known high-risk CNVs are not only associated with schizophrenia and othe
213 ntegrative analysis of focal and large-scale CNV events in multiscale resolution using either bulk or
214 ting that previously reported megabase-scale CNVs in neurons arise at later stages of development.
219 nd chromosomal aneuploidies using a standard CNV detection algorithm not designed for detecting mosai
221 for which SPM data was more predictive than CNV data and the predictive accuracy is good for all mod
223 c multiple myeloma dataset demonstrated that CNV Radar was able to detect a variety of CNVs associate
226 suggest a role for alpha attenuation and the CNV in specific visual content anticipation beyond gener
229 tion of Ro5-3335 significantly decreased the CNV area 7 days after laser injury, and when combined wi
230 "copy number profile curves" to describe the CNV profile of an individual, and the "common area under
231 f CNVs across human diseases, we examine the CNV genomic landscape of 100,028 unrelated individuals o
233 ngal drug can lead to a dramatic loss of the CNV and reversion to the progenitor genotype and drug su
234 2 had a significantly faster decrease of the CNV lesion size, as revealed by in vivo imaging and immu
235 f RPE atrophy in topographic relation to the CNV lesion was then analyzed using mixed-effects logisti
236 usted proportion of clinical visits when the CNV was graded active over 3 years was similar between r
239 cell karyotype analysis indicates that these CNVs appear to arise via a dicentric chromosome intermed
240 nosis of CNV in the fellow eye progressed to CNV fastest (at a rate of 15.2 per 100 person-years), an
241 rates per 100 person-years of progression to CNV (3.2-11.9) or GA (2.0-7.8) in the other subgroups.
249 mples with whole-genome copy-number variant (CNV), whole-exome sequencing, and Assay for Transposase-
250 large and rare copy number genetic variants (CNVs) as well as certain specific CNVs increase the risk
257 16p11.2 and 22q11.2 Copy Number Variants (CNVs) confer high risk for Autism Spectrum Disorder (ASD
258 ich characteristics of copy number variants (CNVs) confer most epilepsy risk and which epilepsy subty
259 ers of large recurrent copy number variants (CNVs) have a higher risk of developing neurodevelopmenta
261 loci including several copy number variants (CNVs) of large effect and hundreds of loci of small effe
262 Functional impact of copy number variants (CNVs) stems from both the proportion of genic and regula
264 No large scale mosaic copy number variants (CNVs) were detectable in normal fetal human brains, sugg
265 gradually accumulates copy number variants (CNVs), and its telomere lengths are short but constant.
266 common to overlapping copy number variants (CNVs), as well as on protein-protein interactions and in
269 ygous SNVs, or de novo copy number variants (CNVs); however, most ASD cases continue to lack a geneti
271 arrangements and gene copy number variation (CNV) are two important tools for genome evolution and so
273 nt mutation (SPM) and copy number variation (CNV) data, gene-level and pathway-level models for a div
274 Cancer associated copy number variation (CNV) events provide important information for identifyin
278 rpretation of genomic copy number variation (CNV) remains a challenge and has important consequences
279 haptoglobin) exhibit copy number variation (CNV), giving rise to HP1 and HP2 alleles, which influenc
280 ors (ASCAT) assesses copy number variations (CNV) while accounting for aberrant cell fraction and tum
283 rs caused by genomic copy number variations (CNVs) and gene expression data from healthy subjects.
288 and duplications are copy number variations (CNVs) that predispose to developmental neuropsychiatric
289 one of the predicted copy number variations (CNVs) were identified, which confirmed the results of SN
290 s) to large, complex copy number variations (CNVs), have been reported in patients with ID and other
291 rs prevalent genomic copy number variations (CNVs), leading to mis-expression of ~68% of SRGs during
292 deletions (indels), copy-number variations (CNVs), loss of heterozygosity (LOH) and complex rearrang
293 which are pathogenic copy number variations (CNVs), play an important role in the initiation and prog
299 resistance to MD, we performed a genome-wide CNV detection using next generation sequencing on the in